Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-Methyl-4-[(4-nitrophenoxy)methyl]piperidine → 4-((1-Methyl-4-piperidinyl)methoxy)benzenamine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-Methyl-4-[(4-nitrophenoxy)methyl]piperidine | HCID 11594000 | — |
| 반응물 | [4-(2-Morpholin-4-yl-ethoxy)-phenyl]-[5-(1H-pyrazol-4-yl)-imidazo[1,2-a]pyrazin-8-yl]amine | HCID 59023066 | — |
| 촉매 | Palladium hydroxide | HCID 9942167 | — |
| 용매 | Ethanol | HCID 702 | — |
| 생성물 | 4-((1-Methyl-4-piperidinyl)methoxy)benzenamine | HCID 11564798 | — |
반응 단계
In the same way as described for Compound 150, step 1, using 1-methyl-4-(4-nitro-phenoxymethyl)-piperidine (0.65 g, 2.6 mmol) in ethanol (40 mL) and palladium hydroxide (0.182 g, 0.26 mmol). Filtration over Celite 521 and evaporation gave a red oil that was purified by silica gel column chromatography eluting with DCM and a 80:20 mixture DCM:MeOH. The title compound was obtained as a white solid (0.402 g, 70%). 1H-NMR (400 MHz, CDCl3) δ (ppm) 1.30-1.51 (2H, m), 1.65-1.88 (3H, m), 1.89-2.09 (2H, t), 2.29 (3H, s), 2.90 (2H, d), 3.45 (2H, br s), 3.73 (2H, d), 6.67 (2H, d), 6.75 (2H, d).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08173656B2 |
| 출처 데이터셋 | uspto-grants-2012_05 |
| ORD ID | ord-83a71afe8d3b4883ad30f7ec9bb15ecf |
| 출처 메모 | uspto-grants-2012_05 |